Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) has completed two government-funded research and development projects that have led to innovation in the cannabis extraction process, the company announced Monday.
The company worked for a year with the National Research Council of Canada Industrial Research Assistance Program to develop a treatment process to remove chlorophyll, carotenoids and other elements from crude cannabis extract. The project used common hops, which are genetically related to cannabis and have similar pigments and oils.
The treatment will be integrated into Nextleaf’s production of distillates for vapes, edibles, and beverages once legalization occurs in Canada.
"Chlorophyll and other pigments can affect the consumer experience in a number of ways, including inferior taste and appearance," said Krupal Pal, who led the project for Nextleaf. "More importantly chlorophyll can affect the functionality of vape hardware as it has a different temperature tolerance and vaporizes at a different rate compared to THC and CBD."
The Vancouver-based company also worked with the University of British Columbia and the British Columbia Institute of Technology on a project to repurpose cannabis biomass after extraction.
Nextleaf discovered that burning hemp biomass creates an ash that can be used as an ingredient to make cement, thus keeping metric tons of biomass out of landfills.
"We were adamant on finding an environmentally conscious way to put cannabis biomass waste used in our extraction process to good use, and the evidence suggests we've found it," CEO Paul Pedersen said in a statement.
"These two R&D projects speak to Nextleaf's talent for research collaboration and technological innovation, key pillars in our growth strategy."
The work was funded by a grant from the Natural Sciences and Engineering Research Council.
Following the completion of the projects, Nextleaf said, it has filed US patent applications.
The company's stock climbed 1.7% Monday to C$0.61 on the CSE and declined 1.7% to US$0.44 on OTC Markets.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel